DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 990 filers reported holding DANAHER CORPORATION in Q3 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,655,000 | -92.1% | 30,950 | -92.8% | 0.01% | -89.3% |
| Q3 2016 | $33,732,000 | -8.8% | 430,315 | +17.6% | 0.13% | -10.3% |
| Q2 2016 | $36,971,000 | +13.0% | 366,046 | +6.1% | 0.15% | +10.6% |
| Q1 2016 | $32,729,000 | +2.5% | 345,028 | +0.4% | 0.13% | -2.9% |
| Q4 2015 | $31,928,000 | +6.2% | 343,757 | -2.6% | 0.14% | +7.9% |
| Q3 2015 | $30,075,000 | -11.3% | 352,948 | -10.9% | 0.13% | -2.3% |
| Q2 2015 | $33,908,000 | +36.8% | 396,171 | +35.7% | 0.13% | +37.2% |
| Q1 2015 | $24,784,000 | +6.9% | 291,918 | +7.9% | 0.09% | +11.9% |
| Q4 2014 | $23,188,000 | +17.9% | 270,535 | +4.5% | 0.08% | +20.0% |
| Q3 2014 | $19,669,000 | -7.8% | 258,873 | -4.5% | 0.07% | -4.1% |
| Q2 2014 | $21,337,000 | +49.2% | 271,015 | +42.1% | 0.07% | +43.1% |
| Q1 2014 | $14,303,000 | +1.9% | 190,711 | +4.9% | 0.05% | 0.0% |
| Q4 2013 | $14,032,000 | +6.5% | 181,756 | -4.4% | 0.05% | +2.0% |
| Q3 2013 | $13,178,000 | +14.0% | 190,105 | +4.1% | 0.05% | +6.4% |
| Q2 2013 | $11,562,000 | – | 182,655 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |